Leakage decrease detected by dynamic susceptibility-weighted contrast-enhanced perfusion MRI predicts survival in recurrent glioblastoma treated with bevacizumab

1. Hilario, A.
2. Sepulveda, J.M.
3. Hernandez-Lain, A.
4. Salvador, E.
5. Koren, L.
6. Manneh, R.
7. Ruano, Y.
8. Perez-Nuñez, A.
9. Lagares, A.
10. Ramos, A.